Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 01/22 10:20:29 am
65.255 EUR   -1.08%
01/15French court cancels Monsanto weedkiller permit on safety grounds
RE
01/07BAYER : The beginning of the move
01/05BAYER : Gets Leg Up in Case Over Weedkiller
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
01/16/2019 01/17/2019 01/18/2019 01/21/2019 01/22/2019 Date
65.08(c) 64.16(c) 66.5(c) 65.97(c) 65.33 Last
1 875 781 2 023 615 4 321 322 1 769 957 898 135 Volume
+0.09% -1.41% +3.65% -0.80% -0.97% Change
More quotes
Financials (EUR)
Sales 2018 39 255 M
EBIT 2018 7 484 M
Net income 2018 4 910 M
Debt 2018 38 418 M
Yield 2018 4,23%
Sales 2019 46 615 M
EBIT 2019 8 790 M
Net income 2019 4 648 M
Debt 2019 36 679 M
Yield 2019 4,39%
P/E ratio 2018 12,31
P/E ratio 2019 14,28
EV / Sales2018 2,56x
EV / Sales2019 2,12x
Capitalization 62 015 M
More Financials
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and high-performance materials. Sales are distributed by product family as follows: - healthcare products (48.1%): pharmaceutical products intended for the prevention and treatment of cardiovascular... 
Sector
Pharmaceuticals
Calendar
02/27Earnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
01/16BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
01/16BAYER : Roundup Faces New Setback in France
DJ
01/15European nations weigh impact of Brexit on drug supplies
RE
01/15French court cancels Monsanto weedkiller permit on safety grounds
RE
01/15BAYER : Faces New Setback for Roundup Weedkiller in France
DJ
01/15BAYER : Disagrees With French Court Decision on Roundup
DJ
01/15BAYER : Roundup Pro 360 to Be Banned in France, Court Rules
DJ
01/14BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
01/11After Monsanto patent ruling, Indian farmers hope for next-gen GM seeds
RE
01/11BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
More news
Analyst Recommendations on BAYER
More recommendations
Stock Trading Strategies
BAYER - 01/07
The beginning of the move
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
01:24aSAMSUNG BIOLOGICS : South Korean court suspends regulator's disciplinary action ..
RE
01/21Private equity firms circling Nestle's skin health business - sources
RE
01/21EUROPEAN PRESS ROUNDUP : U.K. Dividends Hit Record High in 2018
DJ
01/21GlaxoSmithKline Chairman Philip Hampton to Step Down -- Update
DJ
01/21PHILIP HAMPTON : GSK Chairman Hampton to step down ahead of split
RE
More sector news : Pharmaceuticals - NEC
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 90,9 €
Spread / Average Target 37%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER8.93%70 416
JOHNSON & JOHNSON1.27%350 508
PFIZER-2.57%246 674
NOVARTIS5.66%227 840
ROCHE HOLDING LTD.6.16%223 498
MERCK AND COMPANY-0.71%197 291